Jinmin Lee

Jinmin Lee

Company: Cabaletta Bio

Job title: Head of Cellular & Molecular Immunology


Developing Safe & Efficacious Cellular Therapies For Autoimmune Disease: How Do We Ensure An Acceptable Risk-Benefit Profile? 1:00 pm

CAR-T and other cellular therapies have had huge success in the treatment of hematological malignancies; however, adverse events (AEs) including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) have been observed. For patients with cancer, where mortality is a real concern, these AEs are often considered an acceptable risk in the search…Read more

day: Pre-Conference Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.